Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease

NCT: NCT07731841 · COMPLETED

NCT IDNCT07731841
StatusCOMPLETED
Start Date2021-09-01
Completion2026-06-23
SponsorThe First Affiliated Hospital with Nanjing Medical University (OTHER)
First posted
Last updated

Brief Summary

This study evaluated transcranial magnetic stimulation (TMS) for freezing of gait in patients with Parkinson's disease. Participants with Parkinson's disease and freezing of gait received conventional TMS protocols, and their clinical, gait, and neurophysiological outcomes were assessed. Patients who did not achieve sufficient improvement after conventional TMS were further treated with a combined primary motor cortex and cerebellar stimulation protocol. The study aimed to identify factors associated with differential response to conventional TMS and to explore whether cerebellar stimulation could improve symptoms in treatment-resistant patients.

Frequently Asked Questions

What is Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease?

Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease is a clinical trial registered under NCT07731841. Current status: COMPLETED.

What is the status of NCT07731841?

The current status of NCT07731841 (Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease) is: COMPLETED.

When did Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease start?

Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease started on 2021-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.